Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01033773 · ClinicalTrials.gov registry record · NA

Stop Emergency Room Visits for Hyperglycemia Project - District of Columbia (DC)

A NA study, sponsored by Medstar Health Research Institute.

Completed
Registry status
NA
Development phase
86
Enrollment target

NCT01033773 is a NA study that has completed, run by Medstar Health Research Institute. The registered enrollment target is 86 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01033773, a NA study, has completed, sponsored by Medstar Health Research Institute.

COMPLETED
Registry status
NA
Development phase
86 participants
Enrollment target

Study Summary

To demonstrate that a focused Emergency Department (ED) intervention for uncontrolled hyperglycemia enables safe and effective glycemic management and reduces emergency room re-visits. We assessed hypoglycemia BG \< 60mg/dL; change in mean blood glucose and A1C, and ED revisits for hyperglycemia.

Interventions

  • DRUG Antihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ED using metformin, sulfonylurea and/or insulin
  • BEHAVIORAL Diabetes survival skills self-management education

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2007-09
Est. Completion 2009-01
Phase NA

Sponsor

Medstar Health Research Institute

115 total trials

What the Registry Record Tells You About NCT01033773

The ClinicalTrials.gov registry entry for NCT01033773 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Antihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ED using metformin, sulfonylurea and/or insulin is the first listed.

NCT01033773 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01033773 about?

NCT01033773 is a clinical study titled "Stop Emergency Room Visits for Hyperglycemia Project - District of Columbia (DC)". To demonstrate that a focused Emergency Department (ED) intervention for uncontrolled hyperglycemia enables safe and effective glycemic management and reduces emergency room re-visits. We assessed hypoglycemia BG \< 60mg/dL; change in mean blood glucose and A1C, and ED revisits for hyperglycemia.

What is the current status of trial NCT01033773?

This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2007-09. Estimated completion is 2009-01.

What interventions are being tested in trial NCT01033773?

The interventions under investigation include: Antihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ED using metformin, sulfonylurea and/or insulin (DRUG), Diabetes survival skills self-management education (BEHAVIORAL).

Who is sponsoring clinical trial NCT01033773?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.